EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial ( J‐SUPPORT 2001 Study)

Tatsuo Akechi iD, Toshiaki A Furukawa, Hisashi Noma, Hiroji Iwata, Tatsuya Toyama, Kenji Higaki, Hiromichi Matsuoka, Sadamoto Zenda, Tsuguo Iwatani, Kazuhisa Akahane, Akira Inoue, Yasuaki Sagara und 19 weitere

Psychiatry and Clinical Neurosciences · 2024

DOI: 10.1111/pcn.13657 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Psychiatry and Clinical Neurosciences, 2024. Verfasst von Tatsuo Akechi und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Hauptthemen laut MEDLINE: Smartphone, Depression, Neoplasms, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japanese Ministry of Education, Culture, Science and Technology, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Patients with cancer experience various forms of psychological distress, including depressive symptoms, which can impact quality of life, elevate morbidity risk, and increase medical costs. Psychotherapy and pharmacotherapy are effective for reducing depressive symptoms among patients with cancer, but most patients prefer psychotherapy. This study aimed to develop an efficient and effective smartphone psychotherapy component to address depressive symptom.

Methods

This was a decentralized, parallel‐group, multicenter, open, individually randomized, fully factorial trial. Patients aged ≥20 years with cancer were randomized by the presence/absence of three cognitive‐behavioral therapy (CBT) skills (behavioral activation [BA], assertiveness training [AT], and problem‐solving [PS]) on a smartphone app. All participants received psychoeducation (PE). The primary outcome was change in the patient health questionnaire‐9 (PHQ‐9) total score between baseline and week 8. Secondary outcomes included anxiety.

Results

In total, 359 participants were randomized. Primary outcome data at week 8 were obtained for 355 participants (99%). The week 8 PHQ‐9 total score was significantly reduced from baseline for all participants by −1.41 points (95% confidence interval [CI] −1.89, −0.92), but between‐group differences in change scores were not significant (BA: −0.04, 95% CI −0.75, 0.67; AT: −0.16, 95% CI −0.87, 0.55; PS: −0.19, 95% CI −0.90, 0.52).

Conclusion

As the presence of any of the three intervention components did not contribute to a significant additive reduction of depressive symptoms, we cannot make evidence‐based recommendations regarding the use of specific smartphone psychotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SmartphoneDepressionNeoplasmsCognitive Behavioral TherapyHumansMaleFemaleMiddle AgedAdultAgedPsychotherapyOutcome Assessment, Health CareMobile Applications

Stichwörter der Autor:innen

decentralized clinical trialdepressive symptomsmultiphase optimization strategyneoplasmsmartphone‐based CBT

Autor:innen und Institutionen

  • Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Center for Palliative Care and Psycho-oncology, Nagoya City University Hospital, Nagoya, Japan.
  • Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
  • Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan.
  • Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan.
  • Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

ORCID-Profile: Tatsuo Akechi

Förderung

  • Japanese Ministry of Education, Culture, Science and Technology
  • Japan Agency for Medical Research and Development

Zitieren

APA

Akechi, T., Furukawa, T. A., Noma, H., Iwata, H., Toyama, T., Higaki, K., Matsuoka, H., Zenda, S., Iwatani, T., Akahane, K., Inoue, A., Sagara, Y., Uchida, M., Imai, F., Momino, K., Imaizumi, G., Yamaguchi, T., Mashiko, T., Miyaji, T., …, & J‐SUPPORT 2001 Study group (2024). Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial ( J‐SUPPORT 2001 Study). Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13657

Vancouver

Akechi T, Furukawa TA, Noma H, Iwata H, Toyama T, Higaki K, et al. Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial ( J‐SUPPORT 2001 Study). Psychiatry and Clinical Neurosciences. 2024. doi:10.1111/pcn.13657

BibTeX
@article{Akechi2024,
  author = {Akechi, Tatsuo and Furukawa, Toshiaki A and Noma, Hisashi and Iwata, Hiroji and Toyama, Tatsuya and Higaki, Kenji and Matsuoka, Hiromichi and Zenda, Sadamoto and Iwatani, Tsuguo and Akahane, Kazuhisa and Inoue, Akira and Sagara, Yasuaki and Uchida, Megumi and Imai, Fuminobu and Momino, Kanae and Imaizumi, Gen and Yamaguchi, Takuhiro and Mashiko, Tomoe and Miyaji, Tempei and Horikoshi, Masaru and Sakurai, Naomi and Onishi, Tatsuya and Kanemitsu, Yukihide and Murata, Takeshi and Wanifuchi-Endo, Yumi and Kuroda, Hiroaki and Nishikawa, Ryutaro and Miyashita, Minoru and Abe, Masakazu and Uchitomi, Yosuke and J‐SUPPORT 2001 Study group, J‐SUPPORT 2001 Study group},
  title = {Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial ( J‐SUPPORT 2001 Study)},
  journal = {Psychiatry and Clinical Neurosciences},
  year = {2024},
  doi = {10.1111/pcn.13657}
}
Kostenlos starten →